Stenotrophomonas africana sp. nov., an opportunistic human pathogen in Africa

Int J Syst Bacteriol. 1997 Jan;47(1):160-3. doi: 10.1099/00207713-47-1-160.

Abstract

A gram-negative bacterium was isolated from a cerebrospinal fluid sample from an HIV-seropositive Rwandan refugee with primary meningoencephalitis. This Marseille-Goma sample B isolate, strain MGBT (T = type strain), was found to exhibit evolutionary homology with Stenotrophomonas maltophilia, as determined by a 16S rRNA gene sequence analysis, and this finding was reflected by similar phenotypic traits. MGBT could, however, be distinguished from the S. maltophilia type strain by using a number of biochemical and physiological tests, and a genotypic analysis of the two strains in which DNA homology was used revealed only 35% homology between them. Furthermore, the antibiotic susceptibility of MGBT was restricted to netilmicin, ciprofloxacin, trimethoprim-sulfamethoxazole, and colimycin. On the basis of these results we propose that MGBT is a representative of a new species in the genus Stenotrophomonas, Stenotrophomonas africana.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteriological Techniques
  • Culture Media / metabolism
  • DNA, Bacterial / analysis
  • Fatty Acids / analysis
  • HIV Infections / cerebrospinal fluid
  • HIV Infections / complications
  • HIV Infections / microbiology
  • Humans
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Nucleic Acid Hybridization
  • Phylogeny
  • RNA, Ribosomal, 16S / genetics
  • Sequence Homology, Nucleic Acid
  • Xanthomonas / classification*
  • Xanthomonas / genetics
  • Xanthomonas / isolation & purification
  • Xanthomonas / metabolism

Substances

  • Culture Media
  • DNA, Bacterial
  • Fatty Acids
  • RNA, Ribosomal, 16S

Associated data

  • GENBANK/U62646